HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
批准号:
3878145
负责人:
R SCHNEERSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Cryptococcus neoformans Haemophilus influenzae Haemophilus influenzae vaccines Neisseria meningitidis Neisseria meningitidis vaccine Pseudomonas aeruginosa Streptococcus agalactiae Streptococcus pneumoniae Streptococcus pneumoniae vaccine Streptococcus vaccine antibacterial antibody bacterial antigens bacterial capsules bacterial polysaccharides bactericidal immunity child (0-11) drug adverse effect exotoxins fungal vaccines human age group human subject immunization immunoconjugates immunoglobulins immunological substance infant human (0-1 year) laboratory mouse tetanus toxoid
中文摘要
血友病的年龄相关性和t非依赖性免疫特性
英文摘要
The age- related and T-independent immunologic properties of Haemophilus
influenzae type b capsular polysaccharide and other polysaccharides of
invasive bacteria limit their protective actions as vaccines in infants and
children, the age group with the highest attack rate of disease due to
these pathogens. A general organic synthetic scheme, that could bind H.
influenzae type b and other capsular polysaccharides to carrier proteins
was devised in order to both increase the immunogenicity of and confer
T-cell dependence (booster effect) to these protective antigens. Based upon
our, and the work of others, a conjugated Hib vaccine prepared by our
original method was licensed by the FDA for universal use in children
greater than 18 months of age. Now, a license has been extended to other
conjugates and the postmarketing surveillance success of these new products
has lowered the age limits to 15 months of age. We have shown that our H.
influenzae type b-tetanus toxoid conjugate is both safe and immunogenic in
infants at ages 3, 5, 7 and 18 months of age (recommended schedule for
infant vaccines). About 75% of the infants developed protective levels of
antibody with one injection and all were protected after the third
injection. Protective levels of antibodies were induced to the carrier
protein as well. This technology has been extended to Streptococcus group B
type III, Cryptococcus neoformans and to group B meningococcus capsular
polysaccharide which, heretofore, has been considered nonimmunogenic. High
levels of antibodies to this polymer were induced by this conjugate in
mice. Two lots of pneumococcus type 12F-DT conjugate evaluated in adult
volunteers were found to be safe and induce higher levels of type 12F
antibodies than the unconjugated CP vaccine. The lot made with the higher
MW CP induced higher antibody levels. Conjugates of staphylococcal types 5
or 8 and Pseudomonas aeruginosa exotoxin A showed increased immunogenicity
and T-cell dependent properties in mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BACTERIAL POLYSACCHARIDE CROSS-REACTIVE WITH MENINGOCOCCAL GROUP A POLYSACCHARIDE
-
批准号:3965845
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3919310
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3857156
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3965839
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3756711
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3778615
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
BACTERIAL POLYSACCHARIDE CROSS-REACTIVE WITH MENINGOCOCCAL GROUP A POLYSACCHARIDE
-
批准号:4693837
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:5203357
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:2575681
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:6162482
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
ENHANCEMENT OF IMMUNOGENICITY OF CAPSULAR POLYSACCHARIDES PATHOGENIC BACTERIA
-
批准号:4693830
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3842359
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:4693831
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
海外基金